Organovo Holdings, Inc. (ONVO)

Organovo Holdings Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	3.04	15.44	28.82	37.48	27.36
Short-Term Investments	0	0.71	0	0	0
Cash & Cash Equivalents	3.04	16.15	28.82	37.48	27.36
Cash Growth	-81.15%	-43.96%	-23.10%	36.99%	-25.17%
Receivables	0.03	0.15	0	0	0.11
Inventory	0.3	0	0	0	0
Other Current Assets	0.56	0.75	0.72	0.92	0.85
Total Current Assets	3.94	17.05	29.53	38.4	28.32
Property, Plant & Equipment	1.97	2.61	2.82	0.38	0
Other Long-Term Assets	0.45	0.66	0.95	1.14	0.12
Total Long-Term Assets	2.41	3.27	3.76	1.52	0.12
Total Assets	6.35	20.31	33.3	39.92	28.44
Accounts Payable	0.63	0.33	0.42	0.28	0.72
Current Debt	0.51	0.49	0.48	0	0
Other Current Liabilities	0.73	2.85	0.49	0.44	1.09
Total Current Liabilities	1.86	3.67	1.38	0.72	1.81
Long-Term Debt	0.89	1.31	1.7	0	0
Total Long-Term Liabilities	0.89	1.31	1.7	0	0
Total Liabilities	2.75	4.98	3.09	0.72	1.81
Total Debt	1.39	1.81	2.18	0	0
Debt Growth	-22.77%	-17.32%	-	-	-
Retained Earnings	-339.67	-325	-307.74	-296.29	-279.47
Comprehensive Income	0	0	0	0	0
Shareholders' Equity	3.6	15.33	30.21	39.2	26.63
Net Cash / Debt	1.65	14.35	26.64	37.48	27.36
Net Cash / Debt Growth	-88.50%	-46.14%	-28.93%	36.99%	-25.17%
Net Cash Per Share	0.18	1.65	3.06	5.43	4.22
Working Capital	2.08	13.38	28.15	37.68	26.51
Book Value Per Share	0.39	1.76	3.47	5.68	4.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).